Ki Won Seo, MD
Internal Medicine · San Jose
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- Not verified
- Not the same as out of network.
- Offices
- 3
Offices
3 locations · County of Santa Clara · Apogee Medical Group, Louisiana, Inc. · Apogee Medical Group of Pennsylvania PC
Hospitals listed: East Jefferson General Hospital · Saint Vincent Hospital. That is not proof they admit you there this week.
Plan participation
Not verified
We could not verify current plan participation for this doctor. This does not mean they are out of network. Call Dr. Seo’s office to ask if they take your plan before you enroll.
Checkups this office reported
Medicare did not publish checkup rates for this clinician.
- Medicare’s overall office score
- 80.6 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
Hospitals they work in
2 hospitals
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- East Jefferson General HospitalMetairie, LAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of LCMC Health System, which runs 11 hospitalsPatients rate it 4 of 5 · 74% would definitely recommend itOverall rating: 2 of 5 starsBetter than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.464, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.437, Oct 2024 – Sep 2025Better than the national rate — SSI - Colon Surgery: 0.359, Oct 2024 – Sep 2025
- Saint Vincent HospitalErie, PAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of Allegheny Health Network, which runs 11 hospitals in 2 statesPatients rate it 3 of 5 · 71% would definitely recommend itOverall rating: 4 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0.361, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.562, Oct 2024 – Sep 2025
See every measure and the patient survey for East Jefferson General Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 2 better, 6 the same, 0 worse of 8 measures. Readmissions: 0 better, 9 the same, 2 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.464 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.437 | Better | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.359 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 0.95 (0.03 to 1.87) · 1,398 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 1.09 (0.81 to 1.36) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 201.44 (162.02 to 240.86) · 134 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.3 · 93 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 8.9 · 89 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 12.3 · 160 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 10.9 · 409 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 16.8 · 368 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 14.5 · 641 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 5 · 5,487 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.25 (0.05 to 0.45) · 6,900 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.32 (0.12 to 0.51) · 6,995 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.76 (1.84 to 5.68) · 2,058 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.56 (0.09 to 3.03) · 811 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 3.02 (1.71 to 4.32) · 2,059 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 11.91 (6.72 to 17.1) · 956 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.46 (1.25 to 7.66) · 869 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.82 (0.4 to 3.24) · 493 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.71 (0.12 to 1.3) · 5,870 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 4.1 · 70 cases | None | Apr 2023 – Mar 2025 |
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.591 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.534 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 15.8 · 455 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 20.7 · 1,188 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | 59.9 · 164 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 10.9 · 474 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 16.9 · 371 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 17.1 · 868 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 6 (4.2 to 8.5) · 183 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.9 (8.1 to 14.4) · 183 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 62 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 12.8 · 193 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.5 · 343 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 15 (11.3 to 19.9) · 409 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 468 cases | No different | Jan 2024 – Dec 2024 |
What patients said (2,844 patients answered, 21% of those asked)
| Cleanliness | 3 |
| Nurse communication | 4 |
| Doctor communication | 4 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 4 |
| Quietness | 4 |
| Recommend hospital | 4 |
| Room was "always" clean | 70% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 80% |
| Staff "always" explained | 59% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 75% |
| Doctors "always" listened carefully | 78% |
| Doctors "always" treated them with courtesy and respect | 85% |
| Patients who gave a rating of "9" or "10" (high) | 70% |
| Staff "always" explained new medications | 73% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 74% |
| Nurses "always" treated them with courtesy and respect | 83% |
| "Always" quiet at night | 61% |
| "YES", patients would definitely recommend the hospital | 74% |
| Staff "always" explained possible side effects | 45% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
See every measure and the patient survey for Saint Vincent Hospital
Behind the star rating — Deaths: 0 better, 8 the same, 0 worse of 8 measures. Safety: 3 better, 5 the same, 0 worse of 8 measures. Readmissions: 0 better, 10 the same, 1 worse of 11 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0.361 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.562 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.44 (0.5 to 2.38) · 1,093 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.93 (0.61 to 1.24) | No different | Jul 2022 – Jun 2024 |
| Death rate among surgical inpatients with serious treatable complicationsComplications and deaths | 183.74 (133.52 to 233.96) · 66 cases | No different | Jul 2022 – Jun 2024 |
| Death rate for CABG surgery patientsComplications and deaths | 2.1 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for COPD patientsComplications and deaths | 10.4 · 76 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.1 · 190 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 9.6 · 435 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 15.2 · 401 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 13.9 · 249 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.4 · 3,189 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.31 (0.11 to 0.52) · 5,148 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.37 (0.18 to 0.57) · 5,393 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 3.11 (1.04 to 5.19) · 1,309 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.63 (0.12 to 3.14) · 510 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.88 (0.42 to 3.34) · 1,251 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 6.14 (0 to 12.59) · 493 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 5.77 (2.11 to 9.43) · 480 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.9 (0.45 to 3.35) · 243 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.54 (0 to 1.22) · 4,298 cases | No different | Jul 2022 – Jun 2024 |
| Rate of complications for hip/knee replacement patientsComplications and deaths | 5.4 · 81 cases | None | Apr 2023 – Mar 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.461 | No different | Oct 2024 – Sep 2025 |
| MRSA BacteremiaInfections | 0.515 | No different | Oct 2024 – Sep 2025 |
| SSI - Abdominal HysterectomyInfections | 0.845 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 1.857 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 12.6 · 373 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 19.4 · 803 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart attack patientsUnplanned return visits | -0.1 · 194 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 7.9 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | -0.7 · 405 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 15.4 · 759 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 4.2 (2.9 to 6.1) · 229 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 12.5 (9.6 to 16.1) · 229 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission after hip/knee replacementUnplanned return visits | 5.8 · 84 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for CABGUnplanned return visits | 11 · 139 cases | None | Jul 2023 – Jun 2025 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 18.9 · 165 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.5 (10.4 to 17.6) · 1,140 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.3) · 624 cases | No different | Jan 2024 – Dec 2024 |
What patients said (556 patients answered, 25% of those asked)
| Cleanliness | 3 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 2 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 2 |
| Recommend hospital | 4 |
| Room was "always" clean | 66% |
| Nurses "always" communicated well | 77% |
| Doctors "always" communicated well | 73% |
| Staff "always" explained | 57% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 84% |
| Doctors "always" explained things so they could understand | 67% |
| Doctors "always" listened carefully | 71% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 71% |
| Staff "always" explained new medications | 69% |
| Nurses "always" explained things so they could understand | 72% |
| Nurses "always" listened carefully | 76% |
| Nurses "always" treated them with courtesy and respect | 84% |
| "Always" quiet at night | 45% |
| "YES", patients would definitely recommend the hospital | 71% |
| Staff "always" explained possible side effects | 44% |
| Yes, staff "did" give patients information about possible symptoms | 87% |
Original Medicare doctor bills
$51,948
Medicare paid this office $51,948 for 212 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 121 | $24,470 | $93 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 98 | $12,806 | $63 |
| Hospital discharge day management, more than 30 minutes | 120 | $10,820 | $89 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 24 | $3,056 | $127 |
Who their Medicare patients are
212 Original Medicare patients in 2024. Average age 75 · Under 65 14% · 85 and older 22% · Women 50% · Also on Medicaid 31% · Health risk score 2.91. Above the middle of the specialty; the typical hospitalist clinician is at 2.49.
Conditions among them: High blood pressure 75% · Coronary heart disease 52% · Heart failure 51% · Chronic kidney disease 50% · Diabetes 46% · Depression 45% · Atrial fibrillation 44% · Dementia 32% · COPD 28% · Stroke 25% · Cancer 22%.
The office billed $173,445, Medicare allowed $65,796 and paid $51,948; for 624 services of 7 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 212 | 624 | 75 | 2.91 | $173,445 | $51,948 |
| 2023 | 261 | 743 | 75 | 2.96 | $254,896 | $64,071 |
| 2022 | 264 | 762 | 77 | 2.20 | $74,876 | $54,115 |
| 2021 | 284 | 820 | 75 | 2.35 | $86,305 | $61,740 |
| 2020 | 312 | 901 | 74 | 2.42 | $98,008 | $71,606 |
| 2019 | 307 | 942 | 75 | 2.29 | $100,866 | $71,668 |
| 2018 | 312 | 833 | 75 | 2.25 | $77,160 | $56,093 |
| 2017 | 146 | 348 | 74 | 2.10 | $34,881 | $33,614 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 5 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 133 | $25,692 | $96 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 128 | $15,831 | $65 |
| Hospital discharge day management, more than 30 minutes | 132 | $12,651 | $94 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 42 | $5,973 | $142 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,473 | $103 |
2022: 8 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $16,878 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 81 | $15,651 | $80 |
| Hospital discharge day management, more than 30 minutes | 93 | $7,620 | $82 |
| Initial hospital observation care per day, typically 70 minutes | 33 | $4,682 | $142 |
| Hospital observation care on day of discharge | 35 | $1,964 | $56 |
| Initial hospital observation care per day, typically 50 minutes | 17 | $1,536 | $90 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 12 | $1,282 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 18 | $1,096 | $30 |
2021: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 114 | $18,339 | $81 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 138 | $18,012 | $56 |
| Hospital discharge day management, more than 30 minutes | 86 | $7,635 | $83 |
| Initial hospital observation care per day, typically 70 minutes | 37 | $5,150 | $139 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 30 | $4,699 | $157 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,915 | $101 |
| Hospital observation care on day of discharge | 32 | $1,866 | $57 |
| Initial hospital observation care per day, typically 50 minutes | 13 | $1,337 | $103 |
| Follow-up observation care per day, typically 25 minutes | 14 | $1,020 | $57 |
2020: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 136 | $23,308 | $84 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 176 | $20,039 | $58 |
| Hospital discharge day management, more than 30 minutes | 140 | $12,200 | $86 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,780 | $159 |
| Initial hospital observation care per day, typically 70 minutes | 20 | $2,964 | $148 |
| Hospital observation care on day of discharge | 22 | $1,316 | $60 |
2019: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 159 | $21,346 | $57 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 89 | $14,261 | $81 |
| Hospital discharge day management, more than 30 minutes | 119 | $10,119 | $84 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 48 | $7,467 | $156 |
| Initial hospital observation care per day, typically 70 minutes | 42 | $5,963 | $142 |
| Hospital observation care on day of discharge | 65 | $3,765 | $56 |
| Follow-up observation care per day, typically 25 minutes | 36 | $3,264 | $57 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 18 | $1,933 | $107 |
| Subsequent hospital care with straightforward or low level of medical decision making, per day at least 25 minutes | 13 | $494 | $31 |
2018: 9 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 198 | $28,708 | $59 |
| Hospital discharge day management, 30 minutes or less | 111 | $6,627 | $59 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 41 | $4,420 | $108 |
| Initial hospital care with moderate level of medical decision making at least 75 minutes | 23 | $3,648 | $159 |
| Initial hospital observation care per day, typically 50 minutes | 23 | $2,424 | $105 |
| Follow-up observation care per day, typically 25 minutes | 30 | $2,347 | $57 |
| Hospital observation care on day of discharge | 40 | $2,337 | $58 |
| Subsequent hospital care with moderate levelof medical decision making at least 50 minutes | 16 | $1,948 | $81 |
| Hospital discharge day management, more than 30 minutes | 22 | $1,838 | $84 |
2017: 6 services
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 82 | $18,668 | $81 |
| Critical care, first 30-74 minutes | 14 | $3,530 | $252 |
| Hospital discharge day management, 30 minutes or less | 39 | $3,277 | $82 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 17 | $2,625 | $154 |
| Initial hospital observation care per day, typically 50 minutes | 12 | $1,843 | $154 |
| Hospital observation care on day of discharge | 11 | $876 | $80 |
Medicaid work
$841 in 2024
Medicaid paid $841 for 71 billed services this clinician did in 2024, up to 15 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 22 | $302 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 15 | $289 |
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 34 | $250 |
| 2024 | 71 | 3 | 15 | $841 |
| 2023 | 147 | 3 | 23 | $1,566 |
| 2018 | 169 | 4 | 20 | $3,470 |
See the largest Medicaid services in earlier years
2023
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 89 | $1,026 |
| Hospital inpatient or observation discharge day management; more than 30 minutes on the date of the encounter | 32 | $339 |
| SBSQ HOSPITAL IP/OBS CARE HIGH MDM 50 MINUTES | 26 | $201 |
2018
| SBSQ HOSPITAL IP/OBS CARE MOD MDM 35 MINUTES | 87 | $1,754 |
| Hospital observation service, per hour | 29 | $1,394 |
| COMPREHENSIVE METABOLIC PANEL | 26 | $282 |
| Blood count; complete (CBC), automated (Hgb, Hct, RBC, WBC and platelet count) and automated differential WBC count | 27 | $40 |
Drugs they prescribed that Part D paid
$18,803
Pharmacies billed $18,803 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 4% of their Part D prescriptions (17 of 422) in 2024. At or below the middle of the specialty; the typical hospitalist clinician is at 4%.
299 generic and 123 brand-name prescriptions · $18,803 in drug cost · 89 antibiotic prescriptions to 66 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Eliquis | 15 | $9,097 | $606 |
| Lactated Ringers | 58 | $915 | $16 |
| Pantoprazole | 22 | $192 | $9 |
| Amoxicillin-Clavulanate Potass | 26 | $106 | $4 |
| Atorvastatin | 12 | $75 | $6 |
See all 11 drugs
| Eliquis | 15 | $9,097 | $606 |
| Lactated Ringers | 58 | $915 | $16 |
| Pantoprazole | 22 | $192 | $9 |
| Amoxicillin-Clavulanate Potass | 26 | $106 | $4 |
| Atorvastatin | 12 | $75 | $6 |
| Metoprolol | 12 | $50 | $4 |
| Prednisone | 14 | $37 | $3 |
| Hydrocodone-Acetaminophen | 12 | $30 | $2 |
| Magnesium Sulfate | 27 | $27 | $1 |
| Cephalexin | 11 | $26 | $2 |
| Amlodipine Besylate | 13 | $10 | $1 |
Year by year
| 2024 | 422 | 151 | 4% (17) | 29% | $18,803 |
| 2023 | 320 | 161 | 6% (19) | None | $17,007 |
| 2022 | 362 | 165 | 4% (15) | 12% | $18,745 |
| 2021 | 417 | 183 | 6% (23) | None | $21,165 |
| 2020 | 318 | 154 | None | 11% | $14,506 |
| 2019 | 390 | 164 | None | 12% | $16,119 |
| 2018 | 385 | 144 | None | None | $16,187 |
| 2017 | 117 | 38 | None | 19% | $9,162 |
| 2016 | 100 | 14 | None | None | $8,764 |
| 2015 | 134 | 41 | 0% (0) | None | $17,737 |
| 2014 | 96 | 21 | 0% (0) | None | $3,997 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 8 drugs
| Eliquis | 11 | $6,470 | $588 |
| Pantoprazole | 18 | $263 | $15 |
| Amlodipine Besylate | 22 | $93 | $4 |
| Atorvastatin | 14 | $87 | $6 |
| Prednisone | 14 | $74 | $5 |
| Hydrocodone-Acetaminophen | 15 | $62 | $4 |
| Cephalexin | 12 | $58 | $5 |
| Furosemide | 11 | $36 | $3 |
2022: 8 drugs
| Albuterol Sulfate Hfa | 28 | $1,133 | $40 |
| Pantoprazole | 21 | $181 | $9 |
| Prednisone | 26 | $151 | $6 |
| Atorvastatin | 23 | $129 | $6 |
| Lisinopril | 11 | $68 | $6 |
| Amlodipine Besylate | 13 | $51 | $4 |
| Clopidogrel | 11 | $49 | $4 |
| Furosemide | 12 | $33 | $3 |
2021: 12 drugs
| Albuterol Sulfate Hfa | 21 | $868 | $41 |
| Bumetanide | 17 | $503 | $30 |
| Pantoprazole | 31 | $348 | $11 |
| Cephalexin | 11 | $298 | $27 |
| Metoprolol | 11 | $153 | $14 |
| Amoxicillin-Clavulanate Potass | 16 | $106 | $7 |
| Atorvastatin | 11 | $101 | $9 |
| Hydrocodone-Acetaminophen | 17 | $98 | $6 |
| Prednisone | 17 | $96 | $6 |
| Furosemide | 22 | $59 | $3 |
| Amlodipine Besylate | 17 | $50 | $3 |
| Lisinopril | 11 | $30 | $3 |
2020: 6 drugs
| Metoprolol | 17 | $1,365 | $80 |
| Pantoprazole | 25 | $237 | $9 |
| Metoprolol | 14 | $150 | $11 |
| Atorvastatin | 16 | $104 | $7 |
| Prednisone | 18 | $88 | $5 |
| Lisinopril | 11 | $17 | $2 |
2019: 10 drugs
| Metoprolol | 17 | $315 | $19 |
| Pantoprazole | 13 | $145 | $11 |
| Prednisone | 29 | $138 | $5 |
| Atorvastatin | 11 | $110 | $10 |
| Amoxicillin-Clavulanate Potass | 17 | $103 | $6 |
| Carvedilol | 13 | $93 | $7 |
| Lisinopril | 21 | $93 | $4 |
| Metoprolol | 36 | $92 | $3 |
| Cephalexin | 13 | $83 | $6 |
| Furosemide | 16 | $55 | $3 |
2018: 12 drugs
| Ventolin Hfa | 13 | $718 | $55 |
| Atorvastatin | 16 | $178 | $11 |
| Amoxicillin-Clavulanate Potass | 14 | $151 | $11 |
| Isosorbide Mononitrate Er | 14 | $143 | $10 |
| Prednisone | 19 | $117 | $6 |
| Metronidazole | 11 | $103 | $9 |
| Levofloxacin | 13 | $87 | $7 |
| Metoprolol | 18 | $75 | $4 |
| Amlodipine Besylate | 17 | $74 | $4 |
| Carvedilol | 13 | $66 | $5 |
| Furosemide | 14 | $40 | $3 |
| Lisinopril | 12 | $37 | $3 |
2017: 1 drug
| Atorvastatin | 13 | $159 | $12 |
Money from drug and device companies
$162 in 2025
| 2025 | 6 | 8 | None | $162 |
| 2024 | 9 | 32 | None | $854 |
| 2023 | 12 | 34 | None | $736 |
| 2022 | 15 | 57 | None | $1,243 |
| 2021 | 11 | 47 | None | $1,261 |
| 2020 | 3 | 7 | None | $128 |
| 2019 | 8 | 18 | None | $479 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| Recor Medical | Paradise Ultrasound Renal Denervation System | $69 | 3 payments
|
| Abbvie | Teflaro | $27 | 1 payment
|
| Novartis Pharmaceuticals | Leqvio | $23 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Lokelma | $18 | 1 payment
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $17 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $8 | 1 payment
|
See all 8 published payments
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Meals · 2025-11-17 | Lifevest | $8 |
| Recor Medical | Meals · 2025-07-09 | Paradise Ultrasound Renal Denervation System | $20 |
| Recor Medical | Meals · 2025-07-02 | Paradise Ultrasound Renal Denervation System | $25 |
| AstraZeneca Pharmaceuticals LP | Meals · 2025-06-26 | Lokelma | $18 |
| Salix Pharmaceuticals a division of Bausch Health US | Meals · 2025-05-19 | Xifaxan | $17 |
| Recor Medical | Meals · 2025-05-14 | Paradise Ultrasound Renal Denervation System | $25 |
| Abbvie | Meals · 2025-02-26 | Teflaro | $27 |
| Novartis Pharmaceuticals | Meals · 2025-01-29 | Leqvio | $23 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $854
| Novartis Pharmaceuticals | Entresto | $255 | 12 payments
|
| Gilead Sciences | Veklury | $245 | 3 payments
|
| Janssen Pharmaceuticals | Xarelto | $105 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $79 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $64 | 2 payments
|
| Pfizer | Eliquis | $47 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $28 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $16 | 1 payment
|
| Abbvie | Teflaro | $16 | 1 payment
|
2023: $736
| Novartis Pharmaceuticals | Entresto | $156 | 8 payments
|
| Janssen Pharmaceuticals | Xarelto | $113 | 6 payments
|
| Gilead Sciences | None | $87 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Camzyos | $73 | 4 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $63 | 2 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $56 | 2 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $44 | 2 payments
|
| CSL Behring | Kcentra | $38 | 1 payment
|
| Pfizer | Zavzpret | $38 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Farxiga | $33 | 2 payments
|
| Baxter Healthcare | Hillrom - Life 2000 Ventilation System | $18 | 1 payment
|
| Alexion Pharmaceuticals | None | $16 | 1 payment
|
2022: $1,243
| Janssen Pharmaceuticals | Xarelto | $221 | 15 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $197 | 5 payments
|
| Salix Pharmaceuticals a division of Bausch Health US | Xifaxan | $143 | 6 payments
|
| Novartis Pharmaceuticals | Entresto | $115 | 6 payments
|
| Alexion Pharmaceuticals | Soliris | $96 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $88 | 3 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $80 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $75 | 1 payment
|
| Ucb | Briviact | $59 | 2 payments
|
| Pfizer | Eliquis | $46 | 3 payments
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $38 | 2 payments
|
| Baxter Healthcare | Hillrom - Volara System | $37 | 2 payments
|
| Amgen | Repatha | $17 | 1 payment
|
| Abbvie | Teflaro | $16 | 1 payment
|
| Gilead Sciences | Veklury | $16 | 1 payment
|
2021: $1,261
| Janssen Pharmaceuticals | Xarelto | $561 | 18 payments
|
| Alexion Pharmaceuticals | Soliris | $220 | 5 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $155 | 9 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $97 | 3 payments
|
| Novartis Pharmaceuticals | Entresto | $70 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Stiolto Respimat | $48 | 2 payments
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $32 | 2 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $23 | 1 payment
|
| Gilead Sciences | None | $20 | 1 payment
|
| Nestle HealthCare Nutrition | Zenpep | $19 | 1 payment
|
| Bayer HealthCare Pharmaceuticals | Kerendia | $16 | 1 payment
|
2020: $128
| E.R. Squibb & Sons L.L.C. | Eliquis | $96 | 5 payments
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $16 | 1 payment
|
| Pfizer | Eliquis | $15 | 1 payment
|
2019: $479
| Janssen Pharmaceuticals | Xarelto | $165 | 4 payments
|
| Novartis Pharmaceuticals | Entresto | $150 | 3 payments
|
| E.R. Squibb & Sons L.L.C. | Eliquis | $50 | 4 payments
|
| Boehringer Ingelheim Pharmaceuticals | Jardiance | $46 | 3 payments
|
| Advanced Respiratory | The Vest System Model 105 Home Care | $23 | 1 payment
|
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | Lifevest | $20 | 1 payment
|
| AstraZeneca Pharmaceuticals LP | Brilinta | $14 | 1 payment
|
| Regeneron Healthcare Solutions | Praluent | $12 | 1 payment
|
Professional record
- NPI
- 1003236423
- Licence
- NY 290456
- Group
- County of Santa Clara · Apogee Medical Group, Louisiana, Inc. · Apogee Medical Group of Pennsylvania PC
- Gender
- Male
More record details
- Sole proprietor
- No
- Taxonomy
- Hospitalist (208M00000X); Internal medicine (207R00000X)
- Mailing address
- 54 Central Park Rd, Plainview, NY, 11803
- NPI first listed
- 2014-04-24
- NPI last updated
- 2018-01-04
This is when the NPI record was last certified, not a medical board exam.